Antiamyloid therapies for Alzheimer disease recently entered clinical practice, making
imaging biomarkers for Alzheimer disease even more relevant to guiding patient …

Hybrid PET/magnetic resonance (MR) has emerged as a powerful tool in a wide range of
neurologic applications. PET/MR offers particular advantages for brain imaging compared …

Background: The anterior cingulate cortex (ACC) seems to play an important role in
behavioral deficits and executive dysfunctions in patients with behavioral variant …

Purpose The difficulty of dynamic dual‐tracer positron emission tomography (PET)
technology is to separate the complete single‐tracer information from mixed dual‐tracer …

Head motion during MRI compromises image quality for clinical assessments and research.
Active motion reduction strategies are effective but rarely applied due to uncertainty in their …

Objectives Positron emission tomography–magnetic resonance imaging (PET/MRI) is an
emerging hybrid imaging system in clinical nuclear medicine. Research demonstrates a …

Background Posterior cortical atrophy (PCA) and semantic dementia (SD) are focal
syndromes involving different cerebral regions. This study aimed to demonstrate the …

Neurodegenerative diseases (NDDs) are characterized by progressive neuronal loss,
leading to dementia and movement disorders. NDDs broadly include Alzheimer's disease …

Dementia is a significant global health issue that is exacerbated by an aging population.
Imaging plays an established role in the evaluation of patients with neurocognitive disorders …

In 2011, the US Food and Drug Administration (FDA) approved the clinical use of hybrid
PET/MR imaging scan technology, permitting a new era of possibilities and benefits to public …